#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	216	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1099	10.3	0	.	p	.	0	K29T	NONSYN	85	87	AAG	336	338	ACG	16;15;15	A;C;G	16;15;15	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	96	Chlamydophila_psittaci_16S	1507	124	91.13	Chlamydophila_psittaci_16S.l6.c30.ctg.1	236	6.1	0	.	n	.	0	T879G	SNP	879	879	T	130	130	G	3	G	3	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	96	Chlamydophila_psittaci_16S	1507	124	91.13	Chlamydophila_psittaci_16S.l6.c30.ctg.1	236	6.1	0	.	n	.	0	G880A	SNP	880	880	G	131	131	A	3	A	3	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	96	Chlamydophila_psittaci_16S	1507	124	91.13	Chlamydophila_psittaci_16S.l6.c30.ctg.1	236	6.1	0	.	n	.	0	A888G	SNP	888	888	A	139	139	G	2	G	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	96	Chlamydophila_psittaci_16S	1507	124	91.13	Chlamydophila_psittaci_16S.l6.c30.ctg.1	236	6.1	0	.	n	.	0	C897G	SNP	897	897	C	148	148	G	5	G	5	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	96	Chlamydophila_psittaci_16S	1507	124	91.13	Chlamydophila_psittaci_16S.l6.c30.ctg.1	236	6.1	0	.	n	.	0	T898C	SNP	898	898	T	149	149	C	5	C	5	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	96	Chlamydophila_psittaci_16S	1507	124	91.13	Chlamydophila_psittaci_16S.l6.c30.ctg.1	236	6.1	0	.	n	.	0	G906T	SNP	906	906	G	157	157	T	8	T	8	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	96	Chlamydophila_psittaci_16S	1507	124	91.13	Chlamydophila_psittaci_16S.l6.c30.ctg.1	236	6.1	0	.	n	.	0	G908A	SNP	908	908	G	159	159	A	8	A	8	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	96	Chlamydophila_psittaci_16S	1507	124	91.13	Chlamydophila_psittaci_16S.l6.c30.ctg.1	236	6.1	0	.	n	.	0	A918T	SNP	918	918	A	169	169	T	10	T	10	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	96	Chlamydophila_psittaci_16S	1507	124	91.13	Chlamydophila_psittaci_16S.l6.c30.ctg.1	236	6.1	0	.	n	.	0	A943G	SNP	943	943	A	194	194	G	11	G	11	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	602	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l6.c4.ctg.1	1544	19.9	1	SNP	p	R234F	1	.	.	700	702	TTC	849	851	TTC	33;32;33	T;T;C	33;31;33	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	602	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l6.c4.ctg.1	1544	19.9	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1149	1151	CGT	27;27;27	C;G;T	27;26;27	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	602	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l6.c4.ctg.1	1544	19.9	0	HET	.	.	.	C261T	.	261	261	C	410	410	C	21	C,T	13,8	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	602	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l6.c4.ctg.1	1544	19.9	0	HET	.	.	.	T999C	.	999	999	T	1148	1148	T	24	T,C	13,11	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	513	188	Escherichia_coli_mutant_1	1359	910	99.89	Escherichia_coli_mutant_1.l15.c4.ctg.1	910	7.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	513	188	Escherichia_coli_mutant_1	1359	129	99.22	Escherichia_coli_mutant_1.l15.c4.ctg.2	129	5.8	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	120	122	AAA	1;1;1	A;A;A	1;1;1	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	513	188	Escherichia_coli_mutant_1	1359	186	100.0	Escherichia_coli_mutant_1.l15.c4.ctg.3	186	4.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	513	188	Escherichia_coli_mutant_1	1359	111	100.0	Escherichia_coli_mutant_1.l15.c4.ctg.5	155	3.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	296	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c4.ctg.1	1516	10.2	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1144	1146	GAA	14;13;13	G;A;A	14;13;13	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	1	46	H_NS	414	171	99.42	H_NS.l15.c30.ctg.1	171	5.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	1	46	H_NS	414	175	98.29	H_NS.l15.c30.ctg.2	175	4.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	38	G	31	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	38	T	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	43	G	43	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	42	C	42	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	35	C	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	33	T	33	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	46	C	46	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	51	C	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	46	A	46	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	45	A	45	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	45	A	45	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	39	T	39	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	37	C	37	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	32	C	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	30	A	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	26	G	26	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	27	C	27	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	26	T	26	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	35	G	34	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	34	G	34	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	33	T	33	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	32	T	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	32	G	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	28	C	28	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	26	A	26	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	11	C	11	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	11	C	11	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	3	A	3	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	3	A	3	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	3	G	3	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	6	C	6	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	13	T	13	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	16	G	16	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	18	T	18	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	35	C	35	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	844	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l15.c30.ctg.1	549	36.0	0	HET	.	.	.	T1040C	.	1040	1040	T	15	15	T	34	T,C	19,8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	258	PmrB_1	1092	1092	99.27	PmrB_1.l15.c4.ctg.1	1141	11.3	0	.	p	.	0	H2R	NONSYN	4	6	CAT	43	45	CGT	11;12;12	C;G;T	11;12;12	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	258	PmrB_1	1092	1092	99.27	PmrB_1.l15.c4.ctg.1	1141	11.3	0	.	p	.	0	D283G	NONSYN	847	849	GAC	886	888	GGC	14;14;14	G;G;C	14;14;14	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	362	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1919	10.1	0	.	p	.	0	R8S	NONSYN	22	24	AGA	151	153	AGC	2;2;2	A;G;C	2;2;2	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	362	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1919	10.1	0	.	p	.	0	I142L	NONSYN	424	426	ATA	553	555	CTA	7;7;7	C;T;A	7;7;7	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	362	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1919	10.1	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1072	1074	CAA	14;14;14	C;A;A	14;14;14	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	362	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1919	10.1	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1171	1173	GGT	12;13;13	G;G;T	12;13;13	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	362	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1919	10.1	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1741	1743	GTT	4;4;4	G;T;T	4;4;4	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	108	PmrE	1167	566	98.06	PmrE.l15.c4.ctg.1	602	5.4	0	.	p	.	0	A125E	NONSYN	373	375	GCA	402	404	GAA	6;5;5	G;A;A	6;5;5	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	108	PmrE	1167	566	98.06	PmrE.l15.c4.ctg.1	602	5.4	0	.	p	.	0	M185T	NONSYN	553	555	ATG	582	584	ACC	2;2;2	A;C;C	2;2;2	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	108	PmrE	1167	384	95.31	PmrE.l15.c4.ctg.2	384	4.5	0	.	p	.	0	S225T	NONSYN	673	675	TCC	53	55	ACT	3;3;2	A;C;T	3;3;2	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	160	PmrF	969	969	99.38	PmrF.l6.c17.ctg.1	1000	7.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	482	acrD	3114	3114	99.1	acrD.l6.c4.ctg.1	3226	7.8	0	.	p	.	0	T85I	NONSYN	253	255	ACC	335	337	ATC	4;4;3	A;T;C	4;4;3	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	482	acrD	3114	3114	99.1	acrD.l6.c4.ctg.1	3226	7.8	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2048	2050	AAG	8;8;8	A;A,G;G	8;7,1;8	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	130	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.2	846	7.8	1	SNP	p	R45C	0	.	.	133	135	CGC	306	308	CGC	14;13;13	C;G;C	13;13;13	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	152	adiY	762	762	99.61	adiY.l6.c30.ctg.1	914	8.6	0	.	p	.	0	V136L	NONSYN	406	408	GTT	500	502	CTT	13;13;13	C;T;T	13;13;13	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	524	alaS	2631	2631	98.82	alaS.l6.c4.ctg.1	3049	9.2	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2098	2100	GCA	7;7;9	G;C;A	7;6;9	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	524	alaS	2631	2631	98.82	alaS.l6.c4.ctg.1	3049	9.2	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2359	2361	ACC	10;10;10	A;C;C	10;10;10	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	524	alaS	2631	2631	98.82	alaS.l6.c4.ctg.1	3049	9.2	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2668	2670	GCC	9;9;9	G;C;C	9;9;9	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	226	arnA_1	1983	1553	98.65	arnA_1.l6.c4.ctg.1	1618	6.6	0	.	p	.	0	I150V	NONSYN	448	450	ATT	18	20	GTT	5;5;5	G;T;T	5;5;5	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	226	arnA_1	1983	1553	98.65	arnA_1.l6.c4.ctg.1	1618	6.6	0	.	p	.	0	R200H	NONSYN	598	600	CGC	168	170	CAC	5;5;5	C;A;C	5;5;5	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	226	arnA_1	1983	1553	98.65	arnA_1.l6.c4.ctg.1	1618	6.6	0	.	p	.	0	T295M	NONSYN	883	885	ACG	453	455	ATG	11;11;11	A;T;G	11;11;11	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	226	arnA_1	1983	1553	98.65	arnA_1.l6.c4.ctg.1	1618	6.6	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1449	1451	CGC	5;5;5	C;G;C	5;5;5	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	226	arnA_1	1983	92	97.83	arnA_1.l6.c4.ctg.2	92	5.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	226	arnA_1	1983	101	98.02	arnA_1.l6.c4.ctg.3	101	3.9	0	.	p	.	0	G37A	NONSYN	109	111	GGT	4	6	GCT	1;1;2	G;C;T	1;1;2	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	531	150	bacA	822	802	98.63	bacA.l15.c30.ctg.1	881	8.1	0	.	p	.	0	S221T	NONSYN	661	663	AGC	734	736	ACC	5;5;5	A;C;C	5;5;5	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	531	150	bacA	822	802	98.63	bacA.l15.c30.ctg.1	881	8.1	0	.	p	.	0	P225S	NONSYN	673	675	CCG	746	748	TCG	3;3;3	T;C;G	3;3;3	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	19	108	baeR	723	673	97.92	baeR.l15.c4.ctg.1	901	6.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	152	baeS	1404	968	99.38	baeS.l6.c4.ctg.1	987	6.2	0	.	p	.	0	A142T	NONSYN	424	426	GCG	443	445	ACG	12;12;12	A;C;G	12;12;12	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	152	baeS	1404	238	97.06	baeS.l6.c4.ctg.2	238	4.3	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	160	162	AAA	2;2;2	A;A;A	2;2;2	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	152	baeS	1404	238	97.06	baeS.l6.c4.ctg.2	238	4.3	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	172	174	GAG	3;4;4	G;A;G	3;4;4	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	152	baeS	1404	238	97.06	baeS.l6.c4.ctg.2	238	4.3	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	178	180	CAC	4;4;4	C;A;C	4;4;4	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	152	baeS	1404	238	97.06	baeS.l6.c4.ctg.2	238	4.3	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	232	234	GAG	6;6;6	G;A;G	6;6;6	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	152	baeS	1404	79	100.0	baeS.l6.c4.ctg.3	92	3.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	312	cpxA	1374	1374	98.91	cpxA.l6.c30.ctg.1	1714	9.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	174	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1072	8.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	126	cysB	975	975	99.38	cysB.l15.c30.ctg.1	1163	5.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	192	emrA	1173	1173	98.38	emrA.l6.c4.ctg.1	1366	7.2	0	.	p	.	0	I219V	NONSYN	655	657	ATC	781	783	GTC	11;11;11	G;T;C	11;11;11	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	342	emrB	1539	1539	99.81	emrB.l6.c4.ctg.1	1945	9.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	230	emrD	1191	1191	98.57	emrD.l6.c4.ctg.1	1355	8.7	0	.	p	.	0	G209S	NONSYN	625	627	GGC	787	789	AGC	7;7;7	A;G;C	6;6;6	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	513	144	emrK	1056	768	98.05	emrK.l15.c30.ctg.1	788	7.2	0	.	p	.	0	K176R	NONSYN	526	528	AAG	241	243	AGG	4;4;5	A;G;G	4;4;5	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	513	144	emrK	1056	768	98.05	emrK.l15.c30.ctg.1	788	7.2	0	.	p	.	0	N306D	NONSYN	916	918	AAC	631	633	GAC	5;5;5	G;A;C	5;5;5	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	513	144	emrK	1056	196	98.47	emrK.l15.c30.ctg.3	196	4.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	138	emrR	531	531	100.0	emrR.l15.c30.ctg.1	784	8.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	1	228	emrY	1539	1251	99.92	emrY.l6.c4.ctg.1	1414	6.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	1	228	emrY	1539	276	99.28	emrY.l6.c4.ctg.2	457	6.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	513	88	evgA	615	388	98.71	evgA.l6.c4.ctg.1	403	6.7	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	199	201	CTG	7;7;7	C;T;G	7;7;7	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	513	88	evgA	615	388	98.71	evgA.l6.c4.ctg.1	403	6.7	0	.	p	.	0	N128H	NONSYN	382	384	AAC	397	399	CAC	4;4;3	C,A;A;C	0,2;3;2	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	513	88	evgA	615	178	99.44	evgA.l6.c4.ctg.3	178	5.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	460	96.74	evgS.l15.c4.ctg.1	460	5.8	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	193	195	AAA	6;6;6	A;A;A	6;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	120	99.17	evgS.l15.c4.ctg.2	124	7.0	0	.	p	.	0	T38I	NONSYN	112	114	ACA	116	118	ATA	1;1;1	A;T;A	1;1;1	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	2037	98.18	evgS.l15.c4.ctg.3	2038	6.9	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	475	477	CAT	3;3;3	C;A;T	3;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	2037	98.18	evgS.l15.c4.ctg.3	2038	6.9	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	529	531	CAT	3;3;3	C;A;T	3;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	2037	98.18	evgS.l15.c4.ctg.3	2038	6.9	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	547	549	AGA	4;4;3	A;G;A	4;4;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	2037	98.18	evgS.l15.c4.ctg.3	2038	6.9	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	562	564	AAT	3;3;3	A;A;T	3;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	2037	98.18	evgS.l15.c4.ctg.3	2038	6.9	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	709	711	TCC	5;5;5	T;C;C	5;5;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	2037	98.18	evgS.l15.c4.ctg.3	2038	6.9	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	874	876	ATT	3;3;3	A;T;T	3;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	2037	98.18	evgS.l15.c4.ctg.3	2038	6.9	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	895	897	GAT	3;3;4	G;A;T	3;3;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	2037	98.18	evgS.l15.c4.ctg.3	2038	6.9	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1009	1011	GTT	4;4;5	G;T;T	4;4;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	2037	98.18	evgS.l15.c4.ctg.3	2038	6.9	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1294	1296	CAC	4;4;4	C;A;C	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	132	98.48	evgS.l15.c4.ctg.4	132	6.1	0	.	p	.	0	A93T	NONSYN	277	279	GCG	98	100	ACG	5;5;5	A;C;G	5;5;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	186	95.7	evgS.l15.c4.ctg.5	188	4.3	0	.	p	.	0	A114E	NONSYN	340	342	GCA	30	32	GAA	3;4;4	G;A;A	3;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	186	95.7	evgS.l15.c4.ctg.5	188	4.3	0	.	p	.	0	T127A	NONSYN	379	381	ACT	69	71	GCT	6;6;6	G;C;T	6;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	186	95.7	evgS.l15.c4.ctg.5	188	4.3	0	.	p	.	0	N133D	NONSYN	397	399	AAT	87	89	GAT	3;4;4	G;A;T	3;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	186	95.7	evgS.l15.c4.ctg.5	188	4.3	0	.	p	.	0	P162S	NONSYN	484	486	CCA	174	176	TCA	4;4;3	T;C;A	4;4;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	112	95.54	evgS.l15.c4.ctg.6	112	4.8	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	104	106	CAG	1;1;1	C;A;G	1;1;1	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	174	97.7	evgS.l15.c4.ctg.7	174	4.7	0	.	p	.	0	I251V	NONSYN	751	753	ATT	51	53	GTT	5;5;6	G;T;T	5;5;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	416	evgS	3594	115	96.52	evgS.l15.c4.ctg.9	115	4.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	154	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1096	7.4	1	SNP	p	P64H	0	.	.	190	192	CCA	260	262	CCA	11;11;11	C;C;A	11;11;11	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	154	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1096	7.4	1	SNP	p	P64L	0	.	.	190	192	CCA	260	262	CCA	11;11;11	C;C;A	11;11;11	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	154	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1096	7.4	1	SNP	p	P64S	0	.	.	190	192	CCA	260	262	CCA	11;11;11	C;C;A	11;11;11	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	154	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1096	7.4	1	SNP	p	P64A	0	.	.	190	192	CCA	260	262	CCA	11;11;11	C;C;A	11;11;11	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	154	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1096	7.4	1	SNP	p	P64R	0	.	.	190	192	CCA	260	262	CCA	11;11;11	C;C;A	11;11;11	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	94	gadE	528	528	100.0	gadE.l15.c4.ctg.1	693	6.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	0	40	gadW	729	88	97.73	gadW.l6.c4.ctg.1	88	6.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	0	40	gadW	729	124	95.97	gadW.l6.c4.ctg.2	124	4.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	512	134	gadX	825	195	96.92	gadX.l15.c30.ctg.1	195	7.1	0	.	p	.	0	F53L	NONSYN	157	159	TTC	69	71	TTA	7;6;5	T;T;A	7;6;5	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	512	134	gadX	825	195	96.92	gadX.l15.c30.ctg.1	195	7.1	0	.	p	.	0	V79I	NONSYN	235	237	GTT	147	149	ATT	5;5;5	A;T;T	5;4;5	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	512	134	gadX	825	408	98.28	gadX.l15.c30.ctg.2	433	7.8	0	.	p	.	0	R246G	NONSYN	736	738	AGA	322	324	GGA	5;5;5	G;G;A	5;5;5	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	512	134	gadX	825	408	98.28	gadX.l15.c30.ctg.2	433	7.8	0	.	p	.	0	S248P	NONSYN	742	744	TCG	328	330	CCG	6;6;6	C;C;G	5;5;6	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	414	gyrA_7	2628	2628	98.67	gyrA_7.l6.c4.ctg.1	2966	7.5	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2182	2184	GAA	9;9;9	G;A;A	9;8;9	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	414	gyrA_7	2628	2628	98.67	gyrA_7.l6.c4.ctg.1	2966	7.5	1	SNP	p	S83W	0	.	.	247	249	TCG	397	399	TCG	8;8;8	T;C;G	7;7;8	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	414	gyrA_7	2628	2628	98.67	gyrA_7.l6.c4.ctg.1	2966	7.5	1	SNP	p	S83I	0	.	.	247	249	TCG	397	399	TCG	8;8;8	T;C;G	7;7;8	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	414	gyrA_7	2628	2628	98.67	gyrA_7.l6.c4.ctg.1	2966	7.5	1	SNP	p	S83L	0	.	.	247	249	TCG	397	399	TCG	8;8;8	T;C;G	7;7;8	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	414	gyrA_7	2628	2628	98.67	gyrA_7.l6.c4.ctg.1	2966	7.5	1	SNP	p	D87V	0	.	.	259	261	GAC	409	411	GAC	10;12;11	G;A;C	9;11;9	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	414	gyrA_7	2628	2628	98.67	gyrA_7.l6.c4.ctg.1	2966	7.5	1	SNP	p	D87G	0	.	.	259	261	GAC	409	411	GAC	10;12;11	G;A;C	9;11;9	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	414	gyrA_7	2628	2628	98.67	gyrA_7.l6.c4.ctg.1	2966	7.5	1	SNP	p	D87H	0	.	.	259	261	GAC	409	411	GAC	10;12;11	G;A;C	9;11;9	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	414	gyrA_7	2628	2628	98.67	gyrA_7.l6.c4.ctg.1	2966	7.5	1	SNP	p	D87N	0	.	.	259	261	GAC	409	411	GAC	10;12;11	G;A;C	9;11;9	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	414	gyrA_7	2628	2628	98.67	gyrA_7.l6.c4.ctg.1	2966	7.5	1	SNP	p	D87Y	0	.	.	259	261	GAC	409	411	GAC	10;12;11	G;A;C	9;11;9	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	434	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2648	8.6	1	SNP	p	R136L	0	.	.	406	408	CGC	608	610	CGC	6;6;6	C;G;C	6;6;6	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	434	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2648	8.6	1	SNP	p	R136G	0	.	.	406	408	CGC	608	610	CGC	6;6;6	C;G;C	6;6;6	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	434	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2648	8.6	1	SNP	p	R136C	0	.	.	406	408	CGC	608	610	CGC	6;6;6	C;G;C	6;6;6	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	434	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2648	8.6	1	SNP	p	R136I	0	.	.	406	408	CGC	608	610	CGC	6;6;6	C;G;C	6;6;6	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	434	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2648	8.6	1	SNP	p	R136S	0	.	.	406	408	CGC	608	610	CGC	6;6;6	C;G;C	6;6;6	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	434	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2648	8.6	1	SNP	p	R136E	0	.	.	406	408	CGC	608	610	CGC	6;6;6	C;G;C	6;6;6	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	434	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2648	8.6	1	SNP	p	R136H	0	.	.	406	408	CGC	608	610	CGC	6;6;6	C;G;C	6;6;6	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	100	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	773	6.6	0	.	p	.	0	A72P	NONSYN	214	216	GCG	272	274	CCG	9;8;8	C;C;G	9;8;8	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	100	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	773	6.6	0	.	p	.	0	T123A	NONSYN	367	369	ACC	425	427	GCC	6;6;6	G;C;C	6;6;6	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	531	170	leuO	945	945	99.15	leuO.l15.c4.ctg.1	1150	7.7	0	.	p	.	0	P9S	NONSYN	25	27	CCA	31	33	TCA	3;3;3	T;C;A	3;3;3	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	531	170	leuO	945	945	99.15	leuO.l15.c4.ctg.1	1150	7.7	0	.	p	.	0	Q156trunc	TRUNC	466	466	C	472	472	T	9	T	8	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	120	mdfA	1233	192	97.92	mdfA.l15.c30.ctg.1	304	5.2	0	.	p	.	0	L379Q	NONSYN	1135	1137	CTG	94	96	CAG	11;11;11	C;A;G	11;11;11	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	120	mdfA	1233	192	97.92	mdfA.l15.c30.ctg.1	304	5.2	0	.	p	.	0	L391W	NONSYN	1171	1173	TTG	130	132	TGG	5;5;6	T;G;G	5;5;6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	120	mdfA	1233	192	97.92	mdfA.l15.c30.ctg.1	304	5.2	0	.	p	.	0	L399trunc	TRUNC	1195	1195	T	154	154	T	3	T	3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	120	mdfA	1233	171	98.83	mdfA.l15.c30.ctg.2	172	6.0	0	.	p	.	0	V343D	NONSYN	1027	1029	GTT	146	148	GAT	4;4;4	G;A;T	4;4;4	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	120	mdfA	1233	178	97.75	mdfA.l15.c30.ctg.3	192	5.8	0	.	p	.	0	L231V	NONSYN	691	693	CTT	15	17	GTT	2;2;2	G;T;T	1;1;1	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	120	mdfA	1233	402	98.01	mdfA.l15.c30.ctg.4	402	4.2	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	95	97	CAG	7;7;7	C;A;G	7;7;7	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	120	mdfA	1233	402	98.01	mdfA.l15.c30.ctg.4	402	4.2	0	.	p	.	0	D128A	NONSYN	382	384	GAC	134	136	GCC	4;4;4	G;C;C	4;4;4	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	120	mdfA	1233	402	98.01	mdfA.l15.c30.ctg.4	402	4.2	0	.	p	.	0	S163A	NONSYN	487	489	TCG	239	241	GCG	3;3;3	G;C;G	3;3;3	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	132	mdtA	1248	271	97.05	mdtA.l6.c4.ctg.1	274	4.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	132	mdtA	1248	403	99.26	mdtA.l6.c4.ctg.2	403	7.9	0	.	p	.	0	T404P	NONSYN	1210	1212	ACC	373	375	CCC	6;6;6	C,A;C;C	2,3;5;6	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	132	mdtA	1248	472	97.03	mdtA.l6.c4.ctg.3	472	4.1	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	3	5	CAG	2;2;2	C;A;G	2;2;2	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	132	mdtA	1248	472	97.03	mdtA.l6.c4.ctg.3	472	4.1	0	.	p	.	0	T83I	NONSYN	247	249	ACC	153	155	ATC	3;3;3	A;T;C	3;3;3	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	132	mdtA	1248	472	97.03	mdtA.l6.c4.ctg.3	472	4.1	0	.	p	.	0	I99M	NONSYN	295	297	ATA	201	203	ATG	2;2;3	A;T;G	2;2;3	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	132	mdtA	1248	472	97.03	mdtA.l6.c4.ctg.3	472	4.1	0	.	p	.	0	A130T	NONSYN	388	390	GCC	294	296	ACC	4;4;3	A;C;C	4;4;3	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	132	mdtA	1248	472	97.03	mdtA.l6.c4.ctg.3	472	4.1	0	.	p	.	0	T157N	NONSYN	469	471	ACC	375	377	AAC	4;4;4	A;A;C	4;4;4	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	515	482	mdtB	3123	3060	98.92	mdtB.l6.c4.ctg.1	3122	8.1	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1684	1686	ACC	15;15;14	A;C;C	15;15;14	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	515	482	mdtB	3123	3060	98.92	mdtB.l6.c4.ctg.1	3122	8.1	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2077	2079	CAA	4;4;5	C;A;A	4;4;5	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	515	482	mdtB	3123	3060	98.92	mdtB.l6.c4.ctg.1	3122	8.1	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2245	2247	ATT	6;6;6	A;T;T	6;6;6	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	515	482	mdtB	3123	3060	98.92	mdtB.l6.c4.ctg.1	3122	8.1	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2329	2331	GTT	8;8;8	G;T;T	8;8;8	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	515	482	mdtB	3123	3060	98.92	mdtB.l6.c4.ctg.1	3122	8.1	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2437	2439	GAG	6;6;6	G;A;G	6;6;6	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	515	482	mdtB	3123	3060	98.92	mdtB.l6.c4.ctg.1	3122	8.1	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2665	2667	ATG	5;5;5	A;T;G	5;5;5	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	515	482	mdtB	3123	3060	98.92	mdtB.l6.c4.ctg.1	3122	8.1	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	2800	2802	GAT	7;7;7	G;A;T	6;6;7	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	515	482	mdtB	3123	96	98.96	mdtB.l6.c4.ctg.2	149	4.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	513	366	mdtC	3078	130	97.69	mdtC.l15.c4.ctg.1	150	4.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	513	366	mdtC	3078	1508	99.34	mdtC.l15.c4.ctg.3	1508	7.0	0	.	p	.	0	V208I	NONSYN	622	624	GTC	410	412	ATC	5;5;5	A;T;C	5;5;5	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	513	366	mdtC	3078	813	98.4	mdtC.l15.c4.ctg.4	813	6.9	0	.	p	.	0	Y740S	NONSYN	2218	2220	TAC	498	500	TCC	4;4;4	T;C,A;C	2;0,2;4	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	513	366	mdtC	3078	153	97.39	mdtC.l15.c4.ctg.5	156	3.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	513	366	mdtC	3078	180	95.56	mdtC.l15.c4.ctg.7	180	3.0	0	.	p	.	0	V969L	NONSYN	2905	2907	GTA	160	162	CTG	1;1;1	C,G;T;G	0,1;1;1	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	513	366	mdtC	3078	180	95.56	mdtC.l15.c4.ctg.7	180	3.0	0	.	p	.	0	S971M	NONSYN	2911	2913	TCG	166	168	ATG	1;1;1	A,T;T,C;G	0,1;0,1;1	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	513	366	mdtC	3078	79	97.47	mdtC.l15.c4.ctg.8	82	2.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	513	366	mdtC	3078	80	97.5	mdtC.l15.c4.ctg.9	80	3.2	0	.	p	.	0	I46M	NONSYN	136	138	ATC	3	5	ATG	1;1;1	A;T;G	1;1;1	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	513	194	mdtD	1416	1182	98.48	mdtD.l15.c4.ctg.1	1183	7.0	0	.	p	.	0	T226A	NONSYN	676	678	ACG	650	652	GCG	14;14;14	G;C;G	14;14;14	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	513	194	mdtD	1416	1182	98.48	mdtD.l15.c4.ctg.1	1183	7.0	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	992	994	ATC	6;6;6	A;T;C	6;6;6	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	513	194	mdtD	1416	142	99.3	mdtD.l15.c4.ctg.2	142	5.5	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	66	68	TTT	6;5;5	T;T;T	6;5;5	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	282	mdtE	1158	1158	99.31	mdtE.l6.c4.ctg.1	1429	10.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	574	mdtF	3114	3114	98.49	mdtF.l6.c30.ctg.1	3308	9.1	0	.	p	.	0	K208Q	NONSYN	622	624	AAG	780	782	CAG	5;5;5	C,A;A;G	0,5;5;5	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	574	mdtF	3114	3114	98.49	mdtF.l6.c30.ctg.1	3308	9.1	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1041	1043	ACC	8;8;8	A;C;C	8;7;7	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	574	mdtF	3114	3114	98.49	mdtF.l6.c30.ctg.1	3308	9.1	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2283	2285	GAC	13;13;13	G;A;C	11;12;12	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	170	mdtG	1227	735	99.18	mdtG.l6.c30.ctg.1	735	7.6	0	.	p	.	0	V200I	NONSYN	598	600	GTC	108	110	ATC	7;7;7	A;T;C	7;7;7	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	170	mdtG	1227	302	100.0	mdtG.l6.c30.ctg.2	456	4.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	170	mdtG	1227	145	100.0	mdtG.l6.c30.ctg.3	145	4.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	118	mdtH	1209	166	99.4	mdtH.l15.c4.ctg.2	166	4.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	118	mdtH	1209	497	97.38	mdtH.l15.c4.ctg.3	498	4.7	0	.	p	.	0	G134C	NONSYN	400	402	GGT	236	238	TGT	4;4;4	T;G;T	4;4;4	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	118	mdtH	1209	340	99.41	mdtH.l15.c4.ctg.4	340	6.0	0	.	p	.	0	S324L	NONSYN	970	972	TCG	319	321	TTG	5;5;5	T;T;G	5;5;5	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	118	mdtH	1209	176	97.73	mdtH.l15.c4.ctg.5	176	4.0	0	.	p	.	0	L359Q	NONSYN	1075	1077	CTG	76	78	CAG	4;4;4	C;A;G	4;4;4	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	264	mdtL	1176	1176	98.47	mdtL.l15.c4.ctg.1	1526	9.2	0	.	p	.	0	A185S	NONSYN	553	555	GCC	713	715	TCC	4;4;4	T;C;C	4;4;4	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	142	mdtN	1032	1032	98.16	mdtN.l6.c4.ctg.1	1267	5.7	0	.	p	.	0	V119I	NONSYN	355	357	GTT	544	546	ATT	4;5;5	A;T;T	4;5;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	348	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2163	8.4	0	.	p	.	0	V11M	NONSYN	31	33	GTG	46	48	ATG	5;5;5	A;T;G	4;5;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	348	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2163	8.4	0	.	p	.	0	T33I	NONSYN	97	99	ACC	112	114	ATC	3;3;4	A;T;C	3;3;4	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	348	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2163	8.4	0	.	p	.	0	C116R	NONSYN	346	348	TGC	361	363	CGC	9;8;8	C;G;C	9;8;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	348	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2163	8.4	0	.	p	.	0	N238S	NONSYN	712	714	AAC	727	729	AGC	7;7;7	A;G;C	7;7;7	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	348	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2163	8.4	0	.	p	.	0	M305V	NONSYN	913	915	ATG	928	930	GTG	9;9;9	G;T;G	9;8;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	348	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2163	8.4	0	.	p	.	0	D326N	NONSYN	976	978	GAC	991	993	AAC	5;5;5	A;A;C	4;4;4	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	348	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2163	8.4	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1036	1038	GTC	5;6;7	G;T;C	5;6;7	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	348	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2163	8.4	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1066	1068	ATA	8;8;9	A;T;A	8;8;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	348	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2163	8.4	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1174	1176	TCT	4;4;4	T;C;T	4;4;4	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	348	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2163	8.4	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1561	1563	GCG	10;10;11	G;C;G	10;10;11	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	348	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2163	8.4	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1774	1776	ATC	7;7;7	A;T;C	7;7;7	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	528	218	mdtP	1467	1318	98.03	mdtP.l6.c30.ctg.1	1508	6.8	0	.	p	.	0	S129A	NONSYN	385	387	TCA	236	238	GCG	7;7;8	G;C;G	7;7;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	528	218	mdtP	1467	1318	98.03	mdtP.l6.c30.ctg.1	1508	6.8	0	.	p	.	0	A187T	NONSYN	559	561	GCC	410	412	ACC	12;12;12	A;C;C	12;12;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	528	218	mdtP	1467	1318	98.03	mdtP.l6.c30.ctg.1	1508	6.8	0	.	p	.	0	H211R	NONSYN	631	633	CAC	482	484	CGC	10;9;9	C;G;C	10;9;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	528	218	mdtP	1467	1318	98.03	mdtP.l6.c30.ctg.1	1508	6.8	0	.	p	.	0	V250A	NONSYN	748	750	GTT	599	601	GCT	7;8;8	G;C;T	5;7;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	528	218	mdtP	1467	1318	98.03	mdtP.l6.c30.ctg.1	1508	6.8	0	.	p	.	0	R278K	NONSYN	832	834	AGA	683	685	AAA	7;7;6	A;A;A	7;7;6	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	528	218	mdtP	1467	1318	98.03	mdtP.l6.c30.ctg.1	1508	6.8	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	701	703	CGA	4;4;4	C;G;A	4;4;4	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	528	218	mdtP	1467	1318	98.03	mdtP.l6.c30.ctg.1	1508	6.8	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	866	868	GCC	5;5;6	G;C;C	5;5;6	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	528	218	mdtP	1467	1318	98.03	mdtP.l6.c30.ctg.1	1508	6.8	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	878	880	GAT	8;8;8	G;A;T	8;8;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	528	218	mdtP	1467	1318	98.03	mdtP.l6.c30.ctg.1	1508	6.8	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1295	1297	GCT	3;2;2	G;C;T	3;2;2	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	531	428	mfd	3447	3428	99.12	mfd.l6.c4.ctg.1	3592	6.1	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1290	1292	AAG	7;8;8	A;A;G	7;8;8	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	531	428	mfd	3447	3428	99.12	mfd.l6.c4.ctg.1	3592	6.1	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2367	2369	CTG	10;10;10	C;T;G	10;10;10	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	19	22	mgrB	144	138	100.0	mgrB.l6.c30.ctg.1	318	2.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	310	msbA	1749	1749	98.68	msbA.l6.c4.ctg.1	1895	8.6	0	.	p	.	0	S278N	NONSYN	832	834	AGC	955	957	AAC	4;4;4	A;A;C	4;4;3	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	310	msbA	1749	1749	98.68	msbA.l6.c4.ctg.1	1895	8.6	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1501	1503	ATA	8;8;8	A;T;A	8;8;8	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	266	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1535	9.1	0	.	p	.	0	A343V	NONSYN	1027	1029	GCG	1179	1181	GTG	6;6;6	G;T;G	6;6;6	.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	266	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1535	9.1	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1257	1259	GAT	13;13;14	G;A;T	13;13;14	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	266	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1535	9.1	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1260	1262	CTG	12;12;13	C;T;G	12;12;13	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	126	nfsA	723	719	99.03	nfsA.l15.c4.ctg.2	746	7.7	0	.	p	.	0	R27C	NONSYN	79	81	CGT	106	108	TGT	8;7;7	T;G;T	8;7;7	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	126	nfsA	723	719	99.03	nfsA.l15.c4.ctg.2	746	7.7	0	.	p	.	0	I117T	NONSYN	349	351	ATC	376	378	ACC	9;9;9	A;C;C	9;9;9	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	126	nfsA	723	719	99.03	nfsA.l15.c4.ctg.2	746	7.7	0	.	p	.	0	G187D	NONSYN	559	561	GGC	586	588	GAC	9;9;11	G;A;C	9;9;11	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	126	nfsA	723	719	99.03	nfsA.l15.c4.ctg.2	746	7.7	1	SNP	p	R15C	0	.	.	43	45	CGC	70	72	CGC	10;10;10	C;G;C	9;10;10	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	126	nfsA	723	719	99.03	nfsA.l15.c4.ctg.2	746	7.7	1	SNP	p	S33R	0	.	.	97	99	AGC	124	126	AGC	6;6;6	A;G;C	6;6;6	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	126	nfsA	723	719	99.03	nfsA.l15.c4.ctg.2	746	7.7	1	SNP	p	G131D	0	.	.	391	393	GGC	418	420	GGC	8;7;7	G;G;C	8;7;6	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	126	nfsA	723	719	99.03	nfsA.l15.c4.ctg.2	746	7.7	1	SNP	p	R203C	0	.	.	607	609	CGT	634	636	CGT	8;8;7	C;G;T	8;8;7	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	126	nfsA	723	719	99.03	nfsA.l15.c4.ctg.2	746	7.7	1	SNP	p	R203L	0	.	.	607	609	CGT	634	636	CGT	8;8;7	C;G;T	8;8;7	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	16	150	ompF	1089	909	100.0	ompF.l6.c30.ctg.1	1120	6.3	1	SNP	p	G141D	0	.	.	421	423	GGT	241	243	GGT	2;3;3	G;G;T	2;3;3	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	16	150	ompF	1089	909	100.0	ompF.l6.c30.ctg.1	1120	6.3	1	SNP	p	G141E	0	.	.	421	423	GGT	241	243	GGT	2;3;3	G;G;T	2;3;3	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	16	150	ompF	1089	909	100.0	ompF.l6.c30.ctg.1	1120	6.3	1	SNP	p	R154A	0	.	.	460	462	CGT	280	282	CGT	5;5;5	C;G;T	5;5;5	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	16	150	ompF	1089	909	100.0	ompF.l6.c30.ctg.1	1120	6.3	1	SNP	p	R154D	0	.	.	460	462	CGT	280	282	CGT	5;5;5	C;G;T	5;5;5	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	500	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2516	10.3	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1717	1719	TCG	13;13;13	T;C;G	13;13;13	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	500	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2516	10.3	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2332	2334	AAC	10;10;10	A;A;C	9;9;10	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	500	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2516	10.3	1	SNP	p	A85T	0	.	.	253	255	GCG	346	348	GCG	9;9;10	G;C;G	9;9;10	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	500	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2516	10.3	1	SNP	p	D111H	0	.	.	331	333	GAT	424	426	GAT	12;12;13	G;A;T	12;12;13	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	500	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2516	10.3	1	SNP	p	S129P	0	.	.	385	387	TCC	478	480	TCC	4;4;3	T;C;C	4;4;3	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	1	318	parE_1	1893	1022	97.22	parE_1.l6.c4.ctg.1	1031	8.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	1	318	parE_1	1893	759	98.42	parE_1.l6.c4.ctg.2	973	7.7	1	SNP	p	D476N	0	.	.	1426	1428	GAT	341	343	GAT	10;10;10	G;A;T	10;10;10	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	280	patA	1380	1380	99.86	patA.l6.c4.ctg.1	1603	8.7	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1262	1264	GAT	11;11;11	G;A;T	11;11;11	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	864	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4356	10.6	1	SNP	p	V146F	0	.	.	436	438	GTT	589	591	GTT	8;9;9	G;T;T	8;9;9	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	864	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4356	10.6	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1690	1692	CAG	12;11;10	C;A;G	12;11;10	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	864	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4356	10.6	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1690	1692	CAG	12;11;10	C;A;G	12;11;10	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	864	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4356	10.6	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1729	1731	CAC	7;7;7	C;A;C	7;7;6	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	864	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4356	10.6	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1738	1740	CGT	7;5;7	C;G;T	7;5;7	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	864	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4356	10.6	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1738	1740	CGT	7;5;7	C;G;T	7;5;7	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	864	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4356	10.6	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1744	1746	TCC	9;9;9	T;C;C	9;9;9	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	864	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4356	10.6	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1750	1752	CTC	9;10;10	C;T;C	9;10;10	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	864	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4356	10.6	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1840	1842	ACC	13;13;13	A;C;C	13;13;13	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	864	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4356	10.6	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1843	1845	CCT	13;13;12	C;C;T	13;13;12	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	864	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4356	10.6	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2212	2214	CGT	9;9;9	C;G;T	9;9;9	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	0	.	n	.	0	A226G	SNP	226	226	A	368	368	G	69	G	68	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	1	SNP	n	A794T	0	.	.	794	794	A	936	936	A	76	A	75	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	1	SNP	n	A794G	0	.	.	794	794	A	936	936	A	76	A	75	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	1	SNP	n	G926A	0	.	.	926	926	G	1068	1068	G	71	G	71	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	1	SNP	n	G926C	0	.	.	926	926	G	1068	1068	G	71	G	71	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	1	SNP	n	G926T	0	.	.	926	926	G	1068	1068	G	71	G	71	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	1	SNP	n	A1519C	0	.	.	1519	1519	A	1661	1661	A	39	A	38	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	1	SNP	n	A1519T	0	.	.	1519	1519	A	1661	1661	A	39	A	38	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	1	SNP	n	A1519G	0	.	.	1519	1519	A	1661	1661	A	39	A	38	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	0	HET	.	.	.	C183T	.	183	183	C	325	325	C	85	C,T	50,32	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	0	HET	.	.	.	A250T	.	250	250	A	392	392	A	67	A,T	53,14	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	0	HET	.	.	.	T90C	.	90	90	T	232	232	T	58	T,C	45,13	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	0	HET	.	.	.	G474A	.	474	474	G	616	616	G	89	G,A	75,12	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	0	HET	.	.	.	A253T	.	253	253	A	395	395	A	65	A,T	52,13	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	0	HET	.	.	.	C719T	.	719	719	C	861	861	C	71	C,T	42,27	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	0	HET	.	.	.	T1023C	.	1023	1023	T	1165	1165	T	64	T,C	38,12	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	0	HET	.	.	.	C1038T	.	1038	1038	C	1180	1180	C	75	C,T	40,35	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	0	HET	.	.	.	C194T	.	194	194	C	336	336	C	87	C,T	55,31	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	0	HET	.	.	.	G1002A	.	1002	1002	G	1144	1144	G	71	G,A	47,24	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	0	HET	.	.	.	G1006C	.	1006	1006	G	1148	1148	G	75	G,C	50,25	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	0	HET	.	.	.	A79G	.	79	79	A	221	221	A	57	A,G	43,12	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	0	HET	.	.	.	T273A	.	273	273	T	415	415	T	70	T,A	53,17	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2394	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1697	70.7	0	HET	.	.	.	T1010C	.	1010	1010	T	1152	1152	T	75	T,C	53,21	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	104	soxR	465	465	100.0	soxR.l6.c4.ctg.1	734	7.4	1	SNP	p	R20H	0	.	.	58	60	CGC	168	170	CGC	9;9;9	C;G;C	9;9;9	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	104	soxR	465	465	100.0	soxR.l6.c4.ctg.1	734	7.4	1	SNP	p	G121D	0	.	.	361	363	GGT	471	473	GGT	4;5;5	G;G;T	4;5;5	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	66	soxS_1	324	324	99.69	soxS_1.l6.c4.ctg.1	628	5.4	1	SNP	p	A12S	0	.	.	34	36	GCA	151	153	GCA	8;8;9	G;C;A	8;8;9	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	1	292	tolC	1488	1187	98.9	tolC.l15.c30.ctg.1	1286	9.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	1	292	tolC	1488	291	98.28	tolC.l15.c30.ctg.2	357	6.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
